Cargando…
Combination of EP4 antagonist and checkpoint inhibitors promotes anti-tumor effector T cells in preclinical tumor models
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649389/ http://dx.doi.org/10.1186/2051-1426-3-S2-P350 |
_version_ | 1782401347885203456 |
---|---|
author | Bao, Xingfeng Albu, Diana Huang, Kuan-Chun Wu, Jiayi Twine, Natalie Nomoto, Kenichi Woodall-Jappe, Mary |
author_facet | Bao, Xingfeng Albu, Diana Huang, Kuan-Chun Wu, Jiayi Twine, Natalie Nomoto, Kenichi Woodall-Jappe, Mary |
author_sort | Bao, Xingfeng |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4649389 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46493892015-11-24 Combination of EP4 antagonist and checkpoint inhibitors promotes anti-tumor effector T cells in preclinical tumor models Bao, Xingfeng Albu, Diana Huang, Kuan-Chun Wu, Jiayi Twine, Natalie Nomoto, Kenichi Woodall-Jappe, Mary J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649389/ http://dx.doi.org/10.1186/2051-1426-3-S2-P350 Text en Copyright © 2015 Bao et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Bao, Xingfeng Albu, Diana Huang, Kuan-Chun Wu, Jiayi Twine, Natalie Nomoto, Kenichi Woodall-Jappe, Mary Combination of EP4 antagonist and checkpoint inhibitors promotes anti-tumor effector T cells in preclinical tumor models |
title | Combination of EP4 antagonist and checkpoint inhibitors promotes anti-tumor effector T cells in preclinical tumor models |
title_full | Combination of EP4 antagonist and checkpoint inhibitors promotes anti-tumor effector T cells in preclinical tumor models |
title_fullStr | Combination of EP4 antagonist and checkpoint inhibitors promotes anti-tumor effector T cells in preclinical tumor models |
title_full_unstemmed | Combination of EP4 antagonist and checkpoint inhibitors promotes anti-tumor effector T cells in preclinical tumor models |
title_short | Combination of EP4 antagonist and checkpoint inhibitors promotes anti-tumor effector T cells in preclinical tumor models |
title_sort | combination of ep4 antagonist and checkpoint inhibitors promotes anti-tumor effector t cells in preclinical tumor models |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649389/ http://dx.doi.org/10.1186/2051-1426-3-S2-P350 |
work_keys_str_mv | AT baoxingfeng combinationofep4antagonistandcheckpointinhibitorspromotesantitumoreffectortcellsinpreclinicaltumormodels AT albudiana combinationofep4antagonistandcheckpointinhibitorspromotesantitumoreffectortcellsinpreclinicaltumormodels AT huangkuanchun combinationofep4antagonistandcheckpointinhibitorspromotesantitumoreffectortcellsinpreclinicaltumormodels AT wujiayi combinationofep4antagonistandcheckpointinhibitorspromotesantitumoreffectortcellsinpreclinicaltumormodels AT twinenatalie combinationofep4antagonistandcheckpointinhibitorspromotesantitumoreffectortcellsinpreclinicaltumormodels AT nomotokenichi combinationofep4antagonistandcheckpointinhibitorspromotesantitumoreffectortcellsinpreclinicaltumormodels AT woodalljappemary combinationofep4antagonistandcheckpointinhibitorspromotesantitumoreffectortcellsinpreclinicaltumormodels |